MetaADEDB 2.0 @ LMMD
prednisolone phosphate
(VJZLQIPZNBPASX-OJJGEMKLSA-L)
Structure
SMILES
O=C1C=C[C@]2(C(=C1)CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2([C@H]1CC[C@]2(O)C(=O)COP(=O)([O-])[O-])C)C.[Na+].[Na+]
Molecular Formula:
C21H27Na2O8P
Molecular Weight:
484.388
Log P:
2.5510
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
2
TPSA:
156.83
CAS Number(s):
125-02-0
Synonym(s)
1.
prednisolone phosphate
2.
Pediapred
3.
Predsol
4.
prednisolone 21-phosphate sodium
5.
prednisolone phosphate sodium
6.
prednisolone phosphate, monosodium salt, (11beta)-isomer
7.
prednisolone phosphate, sodium salt, (11beta)-isomer
8.
prednisolone sodium phosphate
External Link(s)
MeSHC009022
PubChem Compound58701785
441409
ChEBI8379
CHEMBLCHEMBL1201014
KEGGdr:D00981
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Maternal exposure timing unspecifiedFAERS: 7US FAERS
2Adverse eventFAERS: 6US FAERS
3Low birth weight babyFAERS: 5US FAERS
4UrticariaFAERS: 4US FAERS
5Diabetes MellitusFAERS: 3US FAERS
6PneumoniaFAERS: 3US FAERS
7Retinal DetachmentFAERS: 3US FAERS
8Scedosporium infectionFAERS: 3US FAERS
9SepsisFAERS: 3US FAERS
10AbscessFAERS: 2US FAERS
11CataractFAERS: 2US FAERS
12DroolingFAERS: 2US FAERS
13Drug ineffectiveFAERS: 2US FAERS
14FatigueFAERS: 2US FAERS
15GlaucomaFAERS: 2US FAERS
16PemphigusFAERS: 2US FAERS
17Respiratory distressFAERS: 2US FAERS
18Retinal DrusenFAERS: 2US FAERS
19Throat irritationFAERS: 2US FAERS
20Abdominal PainFAERS: 1US FAERS
21Abdominal discomfortFAERS: 1US FAERS
22Acute kidney injuryFAERS: 1US FAERS
23Amniotic fluid volume decreasedFAERS: 1US FAERS
24Angiogram abnormalFAERS: 1US FAERS
25AnxietyFAERS: 1US FAERS
26AscitesFAERS: 1US FAERS
27AsthenopiaFAERS: 1US FAERS
28Back PainFAERS: 1US FAERS
29Blood sodium decreasedFAERS: 1US FAERS
30Bone TuberculosisFAERS: 1US FAERS
31Bone density decreasedFAERS: 1US FAERS
32BradycardiaFAERS: 1US FAERS
33Bronchopulmonary AspergillosisFAERS: 1US FAERS
34Cardiac dysfunctionFAERS: 1US FAERS
35Corneal OpacityFAERS: 1US FAERS
36CryingFAERS: 1US FAERS
37Deep Vein ThrombosisFAERS: 1US FAERS
38Diastolic dysfunctionFAERS: 1US FAERS
39EcthymaFAERS: 1US FAERS
40Elschnig's bodiesFAERS: 1US FAERS
41Emphysematous cystitisFAERS: 1US FAERS
42Facial paralysisFAERS: 1US FAERS
43Gastric pneumatosisFAERS: 1US FAERS
44Hallucinations, mixedFAERS: 1US FAERS
45HeadacheFAERS: 1US FAERS
46Hepatitis BFAERS: 1US FAERS
47Hepatitis EFAERS: 1US FAERS
48Hypertrophic CardiomyopathyFAERS: 1US FAERS
49HypokinesiaFAERS: 1US FAERS
50HypoperfusionFAERS: 1US FAERS
51HypotensionFAERS: 1US FAERS
52Hypothalamo-pituitary disorderFAERS: 1US FAERS
53HypoxiaFAERS: 1US FAERS
54InfectionFAERS: 1US FAERS
55Intentional product misuseFAERS: 1US FAERS
56Klebsiella sepsisFAERS: 1US FAERS
57Large intestine perforationFAERS: 1US FAERS
58Latent TuberculosisFAERS: 1US FAERS
59Lemierre SyndromeFAERS: 1US FAERS
60Liver AbscessFAERS: 1US FAERS
61Lower respiratory tract infectionFAERS: 1US FAERS
62Lung AbscessFAERS: 1US FAERS
63LymphopeniaFAERS: 1US FAERS
64Macular degenerationFAERS: 1US FAERS
65Macular fibrosisFAERS: 1US FAERS
66Macular pseudoholeFAERS: 1US FAERS
67MalaiseFAERS: 1US FAERS
68Malignant HypertensionFAERS: 1US FAERS
69Meconium Aspiration SyndromeFAERS: 1US FAERS
70Medication ErrorFAERS: 1US FAERS
71Mood swingsFAERS: 1US FAERS
72MyalgiaFAERS: 1US FAERS
73NasopharyngitisFAERS: 1US FAERS
74NauseaFAERS: 1US FAERS
75NecrosisFAERS: 1US FAERS
76Neonatal respiratory failureFAERS: 1US FAERS
77OligohydramniosFAERS: 1US FAERS
78OsteochondrosisFAERS: 1US FAERS
79OsteopeniaFAERS: 1US FAERS
80Peliosis HepatisFAERS: 1US FAERS
81Pharmaceutical product complaintFAERS: 1US FAERS
82PneumoperitoneumFAERS: 1US FAERS
83PneumothoraxFAERS: 1US FAERS
84Poor feeding infantFAERS: 1US FAERS
85Product taste abnormalFAERS: 1US FAERS
86Pulmonary EmbolismFAERS: 1US FAERS
87Retinal exudatesFAERS: 1US FAERS
88ShockFAERS: 1US FAERS
89Sinus TachycardiaFAERS: 1US FAERS
90Soft tissue necrosisFAERS: 1US FAERS
91Steroid diabetesFAERS: 1US FAERS
92Stevens-Johnson SyndromeFAERS: 1US FAERS
93StomatitisFAERS: 1US FAERS
94StrongyloidiasisFAERS: 1US FAERS
95Subcutaneous EmphysemaFAERS: 1US FAERS
96Systolic dysfunctionFAERS: 1US FAERS
97ThrombosisFAERS: 1US FAERS
98TonsillitisFAERS: 1US FAERS
99TremorFAERS: 1US FAERS
100Type 2 lepra reactionFAERS: 1US FAERS
101Unevaluable eventFAERS: 1US FAERS
102Urinary tract infectionFAERS: 1US FAERS
103Varicella Zoster Virus InfectionFAERS: 1US FAERS
104Ventricular FibrillationFAERS: 1US FAERS
105Ventricular arrhythmiaFAERS: 1US FAERS
106VomitingFAERS: 1US FAERS
107Burning sensationCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.